Back to medications
Medication monograph

evolocumab

PCSK9 InhibitorsMonoclonal AntibodiesLipid-Lowering AgentsHypolipidemic Agents Indicated for HyperlipidemiaPCSK9 InhibitorAlirocumab

Clinical reference

Product monograph

REPATHA- evolocumab injection, solutionREPATHA- evolocumab kit

Brands & formulations

Family members

REPATHA

Marketed
140 MGSUBCUTANEOUSSOLUTION[ "evolocumab" ]
Product monograph

REPATHA

Marketed
120 MGSUBCUTANEOUSSOLUTION[ "evolocumab" ]
Product monograph

Pricing

Price information

Repatha Auto Pen Injection (Box of 2) LOCAL PICK ONLY

Amgen · 140 mg/1 ml

1: $931.41

Classification

Chemical class
PCSK9 Inhibitors, Monoclonal Antibodies
Clinical class
Lipid-Lowering Agents
Banks class
Hypolipidemic Agents Indicated for Hyperlipidemia, PCSK9 Inhibitor
AHFS family
Alirocumab